Chemotherapy in Treating Patients With Prostate Cancer
NCT00004045
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
exatecan mesylate
Sponsor
Daiichi Sankyo